Literature DB >> 15160309

In vitro exposure to macrolide antibiotics in Helicobacter pylori strains isolated from children.

Shigeru Fujimura1, Seiichi Kato, Kazuie Iinuma, Akira Watanabe.   

Abstract

Clarithromycin resistance of Helicobacter pylori is a serious problem in eradication therapy. We investigated whether the use of maclorides (clarithromycin, erythromycin, and azithromycin) induces clarithromycin resistance in the organism. Twenty H. pylori strains were isolated from pediatric patients with gastrointestinal symptoms. The minimum inhibitory concentrations (MICs) of each macrolide antibiotic were determined by the Etest. Among these, 17 strains susceptible to macrolide antibiotics were used for the in vitro induction of drug resistance. In each of these 17 strains of H. pylori, 30-day exposure to clarithromycin in experiments for in vitro induction did not change the MIC of any antibiotic, nor did it induce either the A2143G or the A2144G mutation in the 23S rRNA gene. These results suggest that the use of macrolide antibiotics does not induce clarithromycin resistance in H. pylori by 23S rRNA gene mutation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160309     DOI: 10.1007/s10156-004-0300-z

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.

Authors:  Iva Hojsak; Tea Kos; Jelena Dumančić; Zrinjka Mišak; Oleg Jadrešin; Alemka Jaklin Kekez; Amarela Lukić Grlić; Sanja Kolaček
Journal:  Eur J Pediatr       Date:  2012-03-20       Impact factor: 3.183

2.  Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.

Authors:  Hideo Yonezawa; Takako Osaki; Tomoko Hanawa; Satoshi Kurata; Kuniyasu Ochiai; Shigeru Kamiya
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.